XRAY stock gains as UBS upgrades to Buy (NASDAQ:XRAY)
seekingalpha.com
finance
2022-06-02 14:37:44

aluxum/E+ via Getty Images Dentsply Sirona (NASDAQ:XRAY) is trading higher in the morning hours Thursday after UBS upgraded the dental product supplier to Buy from Neutral, noting that the recent concerns that followed the company's 1Q 2022 earnings report could be transitory. The firm points to various issues which came up with the earnings, such as increased inventories, management uncertainty, pandemic, global supply constraints, and lower margins. Citing channel checks and financial analysis, the analysts argue that the concerns 'are explainable and largely transitory.
